GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart disease, Parkinson’s, sleep apnea and addiction.

New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues. More than 28 million adults in the U.S. struggle with alcohol, according to the National Institute on Alcohol Abuse and Alcoholism, making this an important discovery.

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA Psychiatry suggests.

The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published Wednesday in JAMA Psychiatry said. The study examined about 228,000 people in Sweden who had alcohol use disorder and Type 2 diabetes.

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent of their body weight in a year), it also appears to have many benefits beyond just weight loss.

Another day, another study linking Ozempic to major health benefits. In fact, they found it to work even better than the current most-effective drug for treating alcoholism on the market. Syda Productions – stock.